NightHawk Radiology Announces Strategic Alliance


SCOTTSDALE, Ariz., April 12, 2010 (GLOBE NEWSWIRE) -- NightHawk Radiology Services (Nasdaq:NHWK), the largest U.S. provider of professional teleradiology services, and Timaq medical imaging Inc., the leading Swiss Imaging CRO announce a strategic alliance to provide unsurpassed medical imaging services for clinical trials.

This collaboration represents a major step in widening Timaq's services to include greater geographic reach and expanding Timaq's network of expert readers. The synergistic relationship will provide Timaq's customers with faster image evaluation turn-around, closer ties to global imaging sites, assistance with patient recruitment, and reduced inter-reader variability. Both companies have key locations in Zurich allowing close communication and effective consulting for imaging trials.

About NightHawk

NightHawk Radiology (Nasdaq:NHWK) is leading the transformation of the practice of radiology by providing high-quality, cost-effective solutions to radiology groups and hospitals throughout the United States. NightHawk provides the most complete suite of solutions, including professional services, business services, and its advanced, proprietary clinical workflow technology, all designed to increase efficiencies and improve the quality of patient care and the lives of physicians who provide it. NightHawk's team of U.S. board-certified, state-licensed, and hospital-privileged physicians located in the United States, Australia, and Switzerland, provides services 24 hours a day, seven days a week, to approximately 1,600 sites, representing approximately 26% of all hospitals in the United States. For more information, visit http://www.nighthawkrad.net.

The NightHawk Radiology Services logo is available at http://www.globenewswire.com/newsroom/prs/?pkgid=5531

About Timaq medical imaging Inc.                                                                                                                       

Since 2003, Timaq has offered specialized services to customers in the biopharmaceutical industry conducting global phase I-IV clinical trials involving medical imaging as surrogate or primary endpoints. With direct access to radiologists and nuclear medicine physicians at the University Hospital Zurich Timaq provides a direct link to cutting edge research in medical imaging. Timaq is committed to supporting business partners based on scientific expertise in various imaging modalities, operational strengths in trial management, and with web-based workflow solution TimaqView TM. For more information about Timaq medical imaging Inc. please visit http://www.timaq.com.

NHWKG



            

Contact Data